3,252 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 586 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,252
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
1251
$3.52M
1252
$3.52M
1253
$3.5M
1254
$3.5M
1255
$3.49M
1256
$3.48M
1257
$3.46M
1258
$3.46M
1259
$3.46M
1260
$3.46M
1261
$3.46M
1262
$3.46M
1263
$3.46M
1264
$3.46M
1265
$3.44M
1266
$3.43M
1267
$3.41M
1268
$3.4M
1269
$3.4M
1270
$3.4M
1271
$3.39M
1272
$3.39M
1273
$3.38M
1274
$3.38M
1275
$3.37M